Type 2 Inflammation in COPD
COPD is a chronic, heterogeneous, and often progressive inflammatory airway disease that leads to reduced health-related quality of life in patients. Discover more about COPD with type 2 inflammation through a broad selection of medical resources.
- Review the pathophysiologic processes underlying COPD and its clinical consequences
- Understand the complexity and heterogeneous inflammatory pathways involved in COPD
- Gain insights into the burden of type 2 inflammation in COPD patients
- Learn about the key differences between asthma and COPD
Developed by EPG Health for Medthority in collaboration with Sanofi and Regeneron, with content provided by Sanofi and Regeneron. ADVENT is a medical education non-promotional program for healthcare professionals organized by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals.
© 2024 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.
MAT-US-2405120 V1.0 – P Exp Date: 06/11/2026.
Sanofi and Regeneron are committed to providing resources to advance knowledge in areas of unmet medical need among patients with inflammatory and immunologic diseases.